-+ 0.00%
-+ 0.00%
-+ 0.00%

Coherus BioSciences Q1 Adj. EPS $(0.35) Up From $(0.48) YoY, Sales $7.60M Up From $2.31M YoY

Benzinga·05/12/2025 20:23:29
Listen to the news
Coherus BioSciences (NASDAQ:CHRS) reported quarterly losses of $(0.35) per share. This is a 27.08 percent increase over losses of $(0.48) per share from the same period last year. The company reported $7.60 million in sales this quarter. This is a 229.25 percent increase over sales of $2.31 million the same period last year.